Carcinogenesis Advance Access published online on October 29, 2005
Carcinogenesis, doi:10.1093/carcin/bgi254
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202
* To whom correspondence should be addressed. Mitomycin (MMC) induces various types of DNA damages that cause a significant cytotoxicity to cells. Accordingly, repair of MMC-induced damages involves multiple repair pathways such as nucleotide-excision repair, homologous recombination repair, and translesion bypass repair pathways. Nonetheless, repair of the MMC-induced DNA damages in mammals have not been fully delineated. In this study, we investigated potential roles for Xeroderma pigmentosum (XP) proteins in the repair of MMC-induced DNA damages using an assay that detects the ssDNA patches generated following treatment with MMC or 8-methoxy-psoralen (8-MOP) + UVA. Human wildtype cells formed distinctive ssDNA foci following treatment with MMC or 8-MOP + UVA, but not with those inducing alkylation damage, oxidative damage, or strand-break damage, suggesting that the foci represent ssDNA patches formed during the crosslink repair. In contrast to wildtype cells, mutants defective in XPE and XPG did not form the ssDNA foci following MMC treatment, while XPF mutant cells showed a significantly delayed response in forming the foci. A positive role for XPG in the repair of MMC-induced DNA damages was further supported by observations that cells treated with MMC induced a tight association of XPG with chromatin, and a targeted inhibition of XPG abolished MMC-induced ssDNA foci formation, rendering cells hypersensitive to MMC. Together, our results suggest that XPG along with XPE and XPF play unique role(s) in the repair of MMC-induced DNA damages.
Received July 18, 2005
Revised September 27, 2005
Accepted October 26, 2005
CANCER BIOLOGY
An in vivo analysis of MMC-induced DNA damage and its repair
2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202; Department of Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202
3 Department of Microbiology, Indiana University School of Medicine, Indianapolis, Indiana 46202
4 Inje University, Kimhae, Korea
Suk-Hee Lee, E-mail: slee{at}iupui.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Toyooka and Y. Ibuki Histone Deacetylase Inhibitor Sodium Butyrate Enhances the Cell Killing Effect of Psoralen plus UVA by Attenuating Nucleotide Excision Repair Cancer Res., April 15, 2009; 69(8): 3492 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Casado, P. Rio, E. Marco, V. Garcia-Hernandez, A. Domingo, L. Perez, J. C. Tercero, J. J. Vaquero, B. Albella, F. Gago, et al. Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin Mol. Cancer Ther., May 1, 2008; 7(5): 1309 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-P. Chen, A. Mannuss, N. Orel, F. Heitzeberg, and H. Puchta A Homolog of ScRAD5 Is Involved in DNA Repair and Homologous Recombination in Arabidopsis Plant Physiology, April 1, 2008; 146(4): 1786 - 1796. [Abstract] [Full Text] [PDF] |
||||


